This technology is a machine learning model that can predict post-CRISPR gene expression in human cell types.
CRISPR is a technology that enables researchers to edit parts of the genome by removing, adding, or mutating sections of DNA. Although a powerful tool, CRISPR experiments are labor-intensive and often confounded by environmental factors, making probing gene expression effects a difficult process that may not yield scalable results. There is a need for tools and methods that can improve the efficiency and scalability of genetic research using CRISPR.
This technology describes a computational pipeline that predicts gene expression data in human cell types. The model is trained from published human single-cell multi-omics data and accurately predicts gene expression in that cell type from chromatin accessibility data. The ability to perform in silico CRISPR enables a more effective strategy for choosing how to edit the genome in both research and therapeutic applications.
Patent Pending(WO2024178321)
IR CU23168
Licensing Contact: Joan Martinez